Finance News – U.S.

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Investors Ceo Stock Shares Earnings Stocks Eqs Cet China Nasdaq Investment Markets Wall Street Tesla Inflation Nvidia Trade Revenue Stock Market Securities Class Action Federal Reserve Company Economy Bitcoin Us Interest Rates Prices Sales Sp 500 Apple Pvr Ipo Trade War Crypto Amazon Companies Shareholders Monetary Policy German Securities Trading Act Gop Federal Securities Laws Voting Rights Guidance Warren Buffett Trading Elon Musk Llp Investor Treasury Secretary Treasury Demand Metric Interest Rate Hbm Quarterly Revenue Support Layoff Portfolios Media

Filter by:

Regeneron Pharmaceuticals × U.S. × Past month ×

CNBC Business • May 27, 2025

23andMe to delist from Nasdaq, deregister with SEC

The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...

Read Full Article →